Stay updated with the latest aurobindo-pharma news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on aurobindo-pharma topics.
New Delhi, Apr 7 (PTI) Aurobindo Pharma on Tuesday said it has received final approval from the US health regulator for its generic version of dapagliflozin tablets used to control blood sugar levels in people with type 2 diabetes. The final approval granted by the US Food & Drug Administration (USFDA) to manufacture and market dapagliflozin tablets is for strengths 5 mg and 10 mg, Aurobindo Pharma said in a regulatory filing. These are bioequivalent and therapeutically equivalent to the refer ...Read More >
New Delhi: US President Donald Trump's decision to impose 100% tariffs on branded and patented drug exports has shaken Indian pharmaceutical markets, despite most of India's $10 billion US sales being in generics. The uncertainty lies in whether complex generics and specialty medicines will be included, a move that could directly impact leading players like Sun Pharma, Dr. Reddy's, Cipla, Zydus Lifesciences, and others. Stocks Facing Highest Exposure Dr. Reddy's emerges as the most vulnerable, ...Read More >
New Delhi, Sep 26 (PTI) Pharma stocks fell in morning trade on Friday as investors grew concerned after US President Donald Trump announced import taxes of 100 per cent on branded and patented pharmaceutical drugs. Wockhardt Ltd tumbled 6.58 per cent, Natco Pharma tanked 5.46 per cent, Sun Pharma dropped 4.96 per cent, Indoco Remedies edged lower by 4.70 per cent, Glenmark Pharma fell by 2.88 per cent, Aurobindo Pharma 2.44 per cent and Dr Reddys dipped 2.31 per cent on the BSE. The BSE health ...Read More >
New Delhi [India], September 26 (ANI): United States President Donald Trump announced on Friday that his administration will impose a 100 per cent tariff on branded and patented pharmaceutical products beginning October 1, 2025, unless the manufacturing companies establish production facilities in the United States. The Indian pharmaceutical sector supplies over 50 per cent of global demand for various vaccines, 40 per cent of generic demand in the US and 25 per cent of all medicines in the UK. ...Read More >
NEW DELHI: The Nifty Pharma index traded negative around 10:51AM(IST)on Wednesday in a weak market. Mankind Pharma Ltd.(up 1.71 per cent), Sun Pharmaceutical Industries Ltd.(up 0.69 per cent), Aurobindo Pharma Ltd.(up 0.63 per cent), Lupin Ltd.(up 0.48 per cent) and Laurus Labs Ltd.(up 0.41 per cent) were among the top gainers. Gland Pharma Ltd.(down 1.66 per cent), Torrent Pharmaceuticals Ltd.(down 1.29 per cent), Natco Pharma Ltd.(down 1.26 per cent), Cipla Ltd.(down 0.57 per cent) and Dr. R ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.